Q3 2026 results · 29 October 2026
Mounjaro and Zepbound brought in $16.1bn, two-thirds of Lilly's revenue.
$16.1Bfrom Mounjaro and Zepbound together
$24.4Brevenue, up 39%
+53%volume growth, while prices fell 15%
Source
Get a note when Eli Lilly reports next.
Whatco sends a short notification with the number that matters, and the full story of the company is a tap away.
Download on the App Store
